CIK 0001645469
- Non-accelerated filer
- Smaller reporting company
Monopar Therapeutics
Sign in to watch- Ticker
- MNPR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 320463781
- Phone
- +1 847-388-0349
- Business address
- 1000 SKOKIE BLVD SUITE 350, WILMETTE, IL, 60091
- 4 Shares withheld for taxes Chief Operating Officer gave up 721 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 2,209 shares (to pay taxes)
- 4 Other disposition 10% owner disposed of 1,433,334 shares (other)
- 4 Open-market buy Chief Financial Officer bought 1,550 shares at $16.25 ($25,188)
- 4 Shares withheld for taxes Chief Executive Officer gave up 1,918 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 535 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Chief Operating Officer gave up 2,019 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 2,998 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 8,684 shares (to pay taxes)
- 4 Open-market buy Chief Operating Officer bought 32,508 shares at an average $0.79 ($25,574)
- 4 Open-market buy Chief Operating Officer bought 36,000 shares at an average $0.91 ($32,894)
- 4 Open-market buy Chief Operating Officer bought 24,000 shares at an average $0.77 ($18,480)
- 4 Open-market buy Chief Operating Officer bought 36,000 shares at an average $0.64 ($23,051)
- 4 Option exercise Chief Executive Officer acquired 84,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Operating Officer gave up 3,098 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 4,082 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 7,172 shares (to pay taxes)
Page 4 of 13 · 247 filings